ODDB.org: Open Drug Database

Swissmedic Registration	65172	Date of registration	16.12.2015
Company name	MSD Merck Sharp & Dohme AG	Revision date
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	08.06.	Revocation Date
Index Therapeuticus (Swissmedic)	08.06.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Noxafil 300mg (18mg/ml)	Konzentrat zur Herstellung einer Infusionslösung	Concentrate for infusion (Posaconazole 300mg / 16.7ml)	J02AC04

2025	©ywesee GmbH